nodes	percent_of_prediction	percent_of_DWPC	metapath
Sparfloxacin—ABCB1—ovarian cancer	0.292	1	CbGaD
Sparfloxacin—TOP2A—Epirubicin—ovarian cancer	0.144	0.279	CbGbCtD
Sparfloxacin—TOP2A—Doxorubicin—ovarian cancer	0.0763	0.148	CbGbCtD
Sparfloxacin—ABCC2—Paclitaxel—ovarian cancer	0.0581	0.113	CbGbCtD
Sparfloxacin—ABCC2—Carboplatin—ovarian cancer	0.0547	0.106	CbGbCtD
Sparfloxacin—ABCC2—Docetaxel—ovarian cancer	0.042	0.0817	CbGbCtD
Sparfloxacin—ABCB1—Topotecan—ovarian cancer	0.0382	0.0744	CbGbCtD
Sparfloxacin—ABCC2—Doxorubicin—ovarian cancer	0.0313	0.0609	CbGbCtD
Sparfloxacin—ABCB1—Vinorelbine—ovarian cancer	0.0269	0.0524	CbGbCtD
Sparfloxacin—ABCB1—Paclitaxel—ovarian cancer	0.0189	0.0368	CbGbCtD
Sparfloxacin—ABCB1—Docetaxel—ovarian cancer	0.0137	0.0266	CbGbCtD
Sparfloxacin—ABCB1—Doxorubicin—ovarian cancer	0.0102	0.0198	CbGbCtD
Sparfloxacin—TOP2A—myometrium—ovarian cancer	0.00195	0.0824	CbGeAlD
Sparfloxacin—TOP2A—uterine cervix—ovarian cancer	0.00152	0.0641	CbGeAlD
Sparfloxacin—TOP2A—decidua—ovarian cancer	0.00144	0.0611	CbGeAlD
Sparfloxacin—TOP2A—endometrium—ovarian cancer	0.00137	0.058	CbGeAlD
Sparfloxacin—TOP2A—uterus—ovarian cancer	0.00126	0.0534	CbGeAlD
Sparfloxacin—TOP2A—bone marrow—ovarian cancer	0.00107	0.0453	CbGeAlD
Sparfloxacin—TOP2A—female gonad—ovarian cancer	0.00103	0.0437	CbGeAlD
Sparfloxacin—SLC22A5—myometrium—ovarian cancer	0.00103	0.0436	CbGeAlD
Sparfloxacin—TOP2A—vagina—ovarian cancer	0.00103	0.0434	CbGeAlD
Sparfloxacin—TOP2A—Docetaxel—Paclitaxel—ovarian cancer	0.00102	0.219	CbGdCrCtD
Sparfloxacin—TOP2A—testis—ovarian cancer	0.000916	0.0388	CbGeAlD
Sparfloxacin—TOP2A—Irinotecan—Topotecan—ovarian cancer	0.000876	0.187	CbGdCrCtD
Sparfloxacin—SLC22A5—uterine cervix—ovarian cancer	0.000803	0.0339	CbGeAlD
Sparfloxacin—ABCC2—female reproductive system—ovarian cancer	0.000776	0.0328	CbGeAlD
Sparfloxacin—TOP2A—G0 and Early G1—RBL2—ovarian cancer	0.00074	0.0646	CbGpPWpGaD
Sparfloxacin—SLC22A5—endometrium—ovarian cancer	0.000726	0.0307	CbGeAlD
Sparfloxacin—TOP2A—lymph node—ovarian cancer	0.000664	0.0281	CbGeAlD
Sparfloxacin—TOP2A—Vindesine—Vinorelbine—ovarian cancer	0.000651	0.139	CbGdCrCtD
Sparfloxacin—ABCC2—testis—ovarian cancer	0.000626	0.0265	CbGeAlD
Sparfloxacin—SLC22A5—female reproductive system—ovarian cancer	0.000601	0.0254	CbGeAlD
Sparfloxacin—ABCC2—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.000576	0.0503	CbGpPWpGaD
Sparfloxacin—SLC22A5—female gonad—ovarian cancer	0.000547	0.0231	CbGeAlD
Sparfloxacin—SLC22A5—vagina—ovarian cancer	0.000544	0.023	CbGeAlD
Sparfloxacin—TOP2A—Paclitaxel—Docetaxel—ovarian cancer	0.000511	0.109	CbGdCrCtD
Sparfloxacin—SLC22A5—testis—ovarian cancer	0.000485	0.0205	CbGeAlD
Sparfloxacin—ABCB1—myometrium—ovarian cancer	0.000479	0.0202	CbGeAlD
Sparfloxacin—ABCB1—embryo—ovarian cancer	0.00046	0.0195	CbGeAlD
Sparfloxacin—ABCC2—lymph node—ovarian cancer	0.000454	0.0192	CbGeAlD
Sparfloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—TP63—ovarian cancer	0.000396	0.0346	CbGpPWpGaD
Sparfloxacin—ABCB1—epithelium—ovarian cancer	0.000376	0.0159	CbGeAlD
Sparfloxacin—ABCB1—uterine cervix—ovarian cancer	0.000373	0.0158	CbGeAlD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—BARD1—ovarian cancer	0.000372	0.0325	CbGpPWpGaD
Sparfloxacin—ABCB1—decidua—ovarian cancer	0.000355	0.015	CbGeAlD
Sparfloxacin—SLC22A5—lymph node—ovarian cancer	0.000352	0.0149	CbGeAlD
Sparfloxacin—TOP2A—Vincristine—Vinorelbine—ovarian cancer	0.000351	0.075	CbGdCrCtD
Sparfloxacin—ABCB1—endometrium—ovarian cancer	0.000337	0.0143	CbGeAlD
Sparfloxacin—TOP2A—G0 and Early G1—CCNE1—ovarian cancer	0.00033	0.0289	CbGpPWpGaD
Sparfloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—YAP1—ovarian cancer	0.000326	0.0285	CbGpPWpGaD
Sparfloxacin—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.000315	0.0275	CbGpPWpGaD
Sparfloxacin—ABCB1—gonad—ovarian cancer	0.000313	0.0132	CbGeAlD
Sparfloxacin—ABCB1—uterus—ovarian cancer	0.00031	0.0131	CbGeAlD
Sparfloxacin—TOP2A—Vinblastine—Vinorelbine—ovarian cancer	0.000282	0.0603	CbGdCrCtD
Sparfloxacin—ABCB1—female reproductive system—ovarian cancer	0.000279	0.0118	CbGeAlD
Sparfloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—FASN—ovarian cancer	0.000266	0.0232	CbGpPWpGaD
Sparfloxacin—ABCC2—Irinotecan Pathway—APC—ovarian cancer	0.000265	0.0232	CbGpPWpGaD
Sparfloxacin—ABCB1—bone marrow—ovarian cancer	0.000263	0.0111	CbGeAlD
Sparfloxacin—ABCB1—female gonad—ovarian cancer	0.000254	0.0107	CbGeAlD
Sparfloxacin—ABCB1—vagina—ovarian cancer	0.000252	0.0107	CbGeAlD
Sparfloxacin—ABCB1—testis—ovarian cancer	0.000225	0.00953	CbGeAlD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	0.000222	0.0194	CbGpPWpGaD
Sparfloxacin—TOP2A—Gastric Cancer Network 1—APC—ovarian cancer	0.000211	0.0185	CbGpPWpGaD
Sparfloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—ovarian cancer	0.000206	0.018	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—RBL2—ovarian cancer	0.000192	0.0168	CbGpPWpGaD
Sparfloxacin—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.00019	0.0166	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—SKP2—ovarian cancer	0.000181	0.0159	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	0.000181	0.0158	CbGpPWpGaD
Sparfloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000181	0.0158	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—TOP1—ovarian cancer	0.000174	0.0152	CbGpPWpGaD
Sparfloxacin—ABCC2—ABC-family proteins mediated transport—ABCB1—ovarian cancer	0.000173	0.0151	CbGpPWpGaD
Sparfloxacin—TOP2A—Idarubicin—Epirubicin—ovarian cancer	0.000171	0.0365	CbGdCrCtD
Sparfloxacin—TOP2A—Daunorubicin—Epirubicin—ovarian cancer	0.000171	0.0365	CbGdCrCtD
Sparfloxacin—TOP2A—Doxorubicin—Epirubicin—ovarian cancer	0.000171	0.0365	CbGdCrCtD
Sparfloxacin—ABCB1—lymph node—ovarian cancer	0.000163	0.00691	CbGeAlD
Sparfloxacin—TOP2A—Daunorubicin—Doxorubicin—ovarian cancer	0.000158	0.0338	CbGdCrCtD
Sparfloxacin—TOP2A—Epirubicin—Doxorubicin—ovarian cancer	0.000158	0.0338	CbGdCrCtD
Sparfloxacin—TOP2A—Idarubicin—Doxorubicin—ovarian cancer	0.000158	0.0338	CbGdCrCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—PPP1CC—ovarian cancer	0.000152	0.0133	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—RSF1—ovarian cancer	0.000149	0.013	CbGpPWpGaD
Sparfloxacin—TOP2A—Gastric Cancer Network 2—CTNNB1—ovarian cancer	0.000136	0.0119	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—HNF1B—ovarian cancer	0.000132	0.0115	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—SKP2—ovarian cancer	0.000128	0.0112	CbGpPWpGaD
Sparfloxacin—Arthralgia—Paclitaxel—ovarian cancer	0.000126	0.000818	CcSEcCtD
Sparfloxacin—Myalgia—Paclitaxel—ovarian cancer	0.000126	0.000818	CcSEcCtD
Sparfloxacin—Chest pain—Paclitaxel—ovarian cancer	0.000126	0.000818	CcSEcCtD
Sparfloxacin—Anxiety—Paclitaxel—ovarian cancer	0.000126	0.000815	CcSEcCtD
Sparfloxacin—Face oedema—Doxorubicin—ovarian cancer	0.000126	0.000815	CcSEcCtD
Sparfloxacin—Nausea—Topotecan—ovarian cancer	0.000125	0.00081	CcSEcCtD
Sparfloxacin—Discomfort—Paclitaxel—ovarian cancer	0.000125	0.000808	CcSEcCtD
Sparfloxacin—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000124	0.000805	CcSEcCtD
Sparfloxacin—Dry mouth—Paclitaxel—ovarian cancer	0.000124	0.0008	CcSEcCtD
Sparfloxacin—Mood swings—Doxorubicin—ovarian cancer	0.000124	0.0008	CcSEcCtD
Sparfloxacin—Diarrhoea—Vinorelbine—ovarian cancer	0.000123	0.000798	CcSEcCtD
Sparfloxacin—Dysgeusia—Docetaxel—ovarian cancer	0.000123	0.000798	CcSEcCtD
Sparfloxacin—Ataxia—Doxorubicin—ovarian cancer	0.000123	0.000794	CcSEcCtD
Sparfloxacin—Nausea—Melphalan—ovarian cancer	0.000123	0.000793	CcSEcCtD
Sparfloxacin—Confusional state—Paclitaxel—ovarian cancer	0.000122	0.000791	CcSEcCtD
Sparfloxacin—Asthma—Epirubicin—ovarian cancer	0.000122	0.000789	CcSEcCtD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCNE1—ovarian cancer	0.000122	0.0106	CbGpPWpGaD
Sparfloxacin—Back pain—Docetaxel—ovarian cancer	0.000122	0.000788	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000121	0.000784	CcSEcCtD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—ovarian cancer	0.00012	0.0105	CbGpPWpGaD
Sparfloxacin—Dry skin—Doxorubicin—ovarian cancer	0.00012	0.000774	CcSEcCtD
Sparfloxacin—Pancreatitis—Epirubicin—ovarian cancer	0.00012	0.000773	CcSEcCtD
Sparfloxacin—Dizziness—Vinorelbine—ovarian cancer	0.000119	0.000771	CcSEcCtD
Sparfloxacin—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000119	0.000771	CcSEcCtD
Sparfloxacin—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000119	0.000771	CcSEcCtD
Sparfloxacin—Angina pectoris—Epirubicin—ovarian cancer	0.000119	0.000768	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000119	0.000768	CcSEcCtD
Sparfloxacin—Tachycardia—Paclitaxel—ovarian cancer	0.000118	0.000765	CcSEcCtD
Sparfloxacin—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000118	0.00076	CcSEcCtD
Sparfloxacin—Bronchitis—Epirubicin—ovarian cancer	0.000117	0.000758	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000117	0.000758	CcSEcCtD
Sparfloxacin—Pancytopenia—Epirubicin—ovarian cancer	0.000116	0.000749	CcSEcCtD
Sparfloxacin—Anorexia—Paclitaxel—ovarian cancer	0.000116	0.000748	CcSEcCtD
Sparfloxacin—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000115	0.000745	CcSEcCtD
Sparfloxacin—Vomiting—Vinorelbine—ovarian cancer	0.000115	0.000741	CcSEcCtD
Sparfloxacin—Dysuria—Epirubicin—ovarian cancer	0.000114	0.000737	CcSEcCtD
Sparfloxacin—Rash—Vinorelbine—ovarian cancer	0.000114	0.000735	CcSEcCtD
Sparfloxacin—Dermatitis—Vinorelbine—ovarian cancer	0.000114	0.000735	CcSEcCtD
Sparfloxacin—Headache—Vinorelbine—ovarian cancer	0.000113	0.000731	CcSEcCtD
Sparfloxacin—Asthma—Doxorubicin—ovarian cancer	0.000113	0.00073	CcSEcCtD
Sparfloxacin—Palpitations—Docetaxel—ovarian cancer	0.000111	0.00072	CcSEcCtD
Sparfloxacin—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000111	0.00072	CcSEcCtD
Sparfloxacin—Pancreatitis—Doxorubicin—ovarian cancer	0.000111	0.000715	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00011	0.000715	CcSEcCtD
Sparfloxacin—TOP2A—Gastric Cancer Network 2—MYC—ovarian cancer	0.00011	0.00964	CbGpPWpGaD
Sparfloxacin—Cough—Docetaxel—ovarian cancer	0.00011	0.000711	CcSEcCtD
Sparfloxacin—Angina pectoris—Doxorubicin—ovarian cancer	0.00011	0.000711	CcSEcCtD
Sparfloxacin—Insomnia—Paclitaxel—ovarian cancer	0.00011	0.000709	CcSEcCtD
Sparfloxacin—Pneumonia—Epirubicin—ovarian cancer	0.000109	0.000707	CcSEcCtD
Sparfloxacin—Convulsion—Docetaxel—ovarian cancer	0.000109	0.000706	CcSEcCtD
Sparfloxacin—Paraesthesia—Paclitaxel—ovarian cancer	0.000109	0.000704	CcSEcCtD
Sparfloxacin—Hypertension—Docetaxel—ovarian cancer	0.000109	0.000703	CcSEcCtD
Sparfloxacin—Bronchitis—Doxorubicin—ovarian cancer	0.000108	0.000702	CcSEcCtD
Sparfloxacin—Dyspnoea—Paclitaxel—ovarian cancer	0.000108	0.000699	CcSEcCtD
Sparfloxacin—TOP2A—Gastric Cancer Network 2—EGFR—ovarian cancer	0.000108	0.00943	CbGpPWpGaD
Sparfloxacin—Somnolence—Paclitaxel—ovarian cancer	0.000108	0.000697	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000108	0.000697	CcSEcCtD
Sparfloxacin—Arthralgia—Docetaxel—ovarian cancer	0.000107	0.000693	CcSEcCtD
Sparfloxacin—Chest pain—Docetaxel—ovarian cancer	0.000107	0.000693	CcSEcCtD
Sparfloxacin—Myalgia—Docetaxel—ovarian cancer	0.000107	0.000693	CcSEcCtD
Sparfloxacin—Pancytopenia—Doxorubicin—ovarian cancer	0.000107	0.000693	CcSEcCtD
Sparfloxacin—Nausea—Vinorelbine—ovarian cancer	0.000107	0.000693	CcSEcCtD
Sparfloxacin—Dyspepsia—Paclitaxel—ovarian cancer	0.000107	0.00069	CcSEcCtD
Sparfloxacin—Stomatitis—Epirubicin—ovarian cancer	0.000106	0.000685	CcSEcCtD
Sparfloxacin—Jaundice—Epirubicin—ovarian cancer	0.000106	0.000685	CcSEcCtD
Sparfloxacin—Urinary tract infection—Epirubicin—ovarian cancer	0.000106	0.000683	CcSEcCtD
Sparfloxacin—Conjunctivitis—Epirubicin—ovarian cancer	0.000106	0.000683	CcSEcCtD
Sparfloxacin—Dysuria—Doxorubicin—ovarian cancer	0.000105	0.000682	CcSEcCtD
Sparfloxacin—Decreased appetite—Paclitaxel—ovarian cancer	0.000105	0.000682	CcSEcCtD
Sparfloxacin—Dry mouth—Docetaxel—ovarian cancer	0.000105	0.000678	CcSEcCtD
Sparfloxacin—Sweating—Epirubicin—ovarian cancer	0.000104	0.000674	CcSEcCtD
Sparfloxacin—Constipation—Paclitaxel—ovarian cancer	0.000104	0.000671	CcSEcCtD
Sparfloxacin—Pain—Paclitaxel—ovarian cancer	0.000104	0.000671	CcSEcCtD
Sparfloxacin—Haematuria—Epirubicin—ovarian cancer	0.000104	0.00067	CcSEcCtD
Sparfloxacin—Confusional state—Docetaxel—ovarian cancer	0.000104	0.00067	CcSEcCtD
Sparfloxacin—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000103	0.000666	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Docetaxel—ovarian cancer	0.000103	0.000665	CcSEcCtD
Sparfloxacin—Epistaxis—Epirubicin—ovarian cancer	0.000103	0.000663	CcSEcCtD
Sparfloxacin—Sinusitis—Epirubicin—ovarian cancer	0.000102	0.00066	CcSEcCtD
Sparfloxacin—Agranulocytosis—Epirubicin—ovarian cancer	0.000101	0.000656	CcSEcCtD
Sparfloxacin—Pneumonia—Doxorubicin—ovarian cancer	0.000101	0.000654	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Docetaxel—ovarian cancer	0.000101	0.000651	CcSEcCtD
Sparfloxacin—Tachycardia—Docetaxel—ovarian cancer	0.0001	0.000649	CcSEcCtD
Sparfloxacin—Feeling abnormal—Paclitaxel—ovarian cancer	9.99e-05	0.000646	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	9.97e-05	0.000645	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Paclitaxel—ovarian cancer	9.91e-05	0.000641	CcSEcCtD
Sparfloxacin—Haemoglobin—Epirubicin—ovarian cancer	9.81e-05	0.000634	CcSEcCtD
Sparfloxacin—Stomatitis—Doxorubicin—ovarian cancer	9.8e-05	0.000634	CcSEcCtD
Sparfloxacin—Jaundice—Doxorubicin—ovarian cancer	9.8e-05	0.000634	CcSEcCtD
Sparfloxacin—Anorexia—Docetaxel—ovarian cancer	9.8e-05	0.000634	CcSEcCtD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CCND2—ovarian cancer	9.79e-05	0.00855	CbGpPWpGaD
Sparfloxacin—Rhinitis—Epirubicin—ovarian cancer	9.78e-05	0.000633	CcSEcCtD
Sparfloxacin—Urinary tract infection—Doxorubicin—ovarian cancer	9.78e-05	0.000632	CcSEcCtD
Sparfloxacin—Conjunctivitis—Doxorubicin—ovarian cancer	9.78e-05	0.000632	CcSEcCtD
Sparfloxacin—Haemorrhage—Epirubicin—ovarian cancer	9.76e-05	0.000631	CcSEcCtD
Sparfloxacin—Hepatitis—Epirubicin—ovarian cancer	9.76e-05	0.000631	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Epirubicin—ovarian cancer	9.71e-05	0.000628	CcSEcCtD
Sparfloxacin—Pharyngitis—Epirubicin—ovarian cancer	9.68e-05	0.000626	CcSEcCtD
Sparfloxacin—Sweating—Doxorubicin—ovarian cancer	9.64e-05	0.000624	CcSEcCtD
Sparfloxacin—Urticaria—Paclitaxel—ovarian cancer	9.63e-05	0.000623	CcSEcCtD
Sparfloxacin—Oedema peripheral—Epirubicin—ovarian cancer	9.61e-05	0.000622	CcSEcCtD
Sparfloxacin—Haematuria—Doxorubicin—ovarian cancer	9.59e-05	0.00062	CcSEcCtD
Sparfloxacin—Body temperature increased—Paclitaxel—ovarian cancer	9.58e-05	0.00062	CcSEcCtD
Sparfloxacin—Abdominal pain—Paclitaxel—ovarian cancer	9.58e-05	0.00062	CcSEcCtD
Sparfloxacin—Epistaxis—Doxorubicin—ovarian cancer	9.49e-05	0.000614	CcSEcCtD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—ovarian cancer	9.46e-05	0.00827	CbGpPWpGaD
Sparfloxacin—Sinusitis—Doxorubicin—ovarian cancer	9.43e-05	0.00061	CcSEcCtD
Sparfloxacin—Agranulocytosis—Doxorubicin—ovarian cancer	9.38e-05	0.000607	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	9.36e-05	0.000606	CcSEcCtD
Sparfloxacin—Insomnia—Docetaxel—ovarian cancer	9.3e-05	0.000601	CcSEcCtD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—PPP2R1A—ovarian cancer	9.23e-05	0.00807	CbGpPWpGaD
Sparfloxacin—Paraesthesia—Docetaxel—ovarian cancer	9.23e-05	0.000597	CcSEcCtD
Sparfloxacin—Erythema multiforme—Epirubicin—ovarian cancer	9.23e-05	0.000597	CcSEcCtD
Sparfloxacin—Dyspnoea—Docetaxel—ovarian cancer	9.16e-05	0.000593	CcSEcCtD
Sparfloxacin—Somnolence—Docetaxel—ovarian cancer	9.14e-05	0.000591	CcSEcCtD
Sparfloxacin—Tinnitus—Epirubicin—ovarian cancer	9.1e-05	0.000588	CcSEcCtD
Sparfloxacin—Haemoglobin—Doxorubicin—ovarian cancer	9.07e-05	0.000587	CcSEcCtD
Sparfloxacin—TOP2A—Gastric Cancer Network 2—TP53—ovarian cancer	9.06e-05	0.00792	CbGpPWpGaD
Sparfloxacin—Rhinitis—Doxorubicin—ovarian cancer	9.05e-05	0.000585	CcSEcCtD
Sparfloxacin—Dyspepsia—Docetaxel—ovarian cancer	9.05e-05	0.000585	CcSEcCtD
Sparfloxacin—Haemorrhage—Doxorubicin—ovarian cancer	9.03e-05	0.000584	CcSEcCtD
Sparfloxacin—Hepatitis—Doxorubicin—ovarian cancer	9.03e-05	0.000584	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Doxorubicin—ovarian cancer	8.98e-05	0.000581	CcSEcCtD
Sparfloxacin—Pharyngitis—Doxorubicin—ovarian cancer	8.96e-05	0.00058	CcSEcCtD
Sparfloxacin—Decreased appetite—Docetaxel—ovarian cancer	8.93e-05	0.000578	CcSEcCtD
Sparfloxacin—Hypersensitivity—Paclitaxel—ovarian cancer	8.93e-05	0.000578	CcSEcCtD
Sparfloxacin—Oedema peripheral—Doxorubicin—ovarian cancer	8.89e-05	0.000575	CcSEcCtD
Sparfloxacin—Constipation—Docetaxel—ovarian cancer	8.79e-05	0.000568	CcSEcCtD
Sparfloxacin—Pain—Docetaxel—ovarian cancer	8.79e-05	0.000568	CcSEcCtD
Sparfloxacin—Chills—Epirubicin—ovarian cancer	8.75e-05	0.000566	CcSEcCtD
Sparfloxacin—Arrhythmia—Epirubicin—ovarian cancer	8.72e-05	0.000564	CcSEcCtD
Sparfloxacin—Asthenia—Paclitaxel—ovarian cancer	8.7e-05	0.000563	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	8.66e-05	0.00757	CbGpPWpGaD
Sparfloxacin—Alopecia—Epirubicin—ovarian cancer	8.62e-05	0.000558	CcSEcCtD
Sparfloxacin—Pruritus—Paclitaxel—ovarian cancer	8.58e-05	0.000555	CcSEcCtD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CCNE1—ovarian cancer	8.57e-05	0.00749	CbGpPWpGaD
Sparfloxacin—Erythema multiforme—Doxorubicin—ovarian cancer	8.54e-05	0.000552	CcSEcCtD
Sparfloxacin—Feeling abnormal—Docetaxel—ovarian cancer	8.47e-05	0.000548	CcSEcCtD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—ovarian cancer	8.47e-05	0.0074	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—TYMS—ovarian cancer	8.42e-05	0.00736	CbGpPWpGaD
Sparfloxacin—Tinnitus—Doxorubicin—ovarian cancer	8.42e-05	0.000544	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Docetaxel—ovarian cancer	8.4e-05	0.000544	CcSEcCtD
Sparfloxacin—Flatulence—Epirubicin—ovarian cancer	8.37e-05	0.000541	CcSEcCtD
Sparfloxacin—Tension—Epirubicin—ovarian cancer	8.33e-05	0.000539	CcSEcCtD
Sparfloxacin—Dysgeusia—Epirubicin—ovarian cancer	8.32e-05	0.000538	CcSEcCtD
Sparfloxacin—Diarrhoea—Paclitaxel—ovarian cancer	8.3e-05	0.000537	CcSEcCtD
Sparfloxacin—Nervousness—Epirubicin—ovarian cancer	8.25e-05	0.000534	CcSEcCtD
Sparfloxacin—Back pain—Epirubicin—ovarian cancer	8.22e-05	0.000531	CcSEcCtD
Sparfloxacin—Abdominal pain—Docetaxel—ovarian cancer	8.12e-05	0.000526	CcSEcCtD
Sparfloxacin—Body temperature increased—Docetaxel—ovarian cancer	8.12e-05	0.000526	CcSEcCtD
Sparfloxacin—Chills—Doxorubicin—ovarian cancer	8.1e-05	0.000524	CcSEcCtD
Sparfloxacin—Arrhythmia—Doxorubicin—ovarian cancer	8.06e-05	0.000522	CcSEcCtD
Sparfloxacin—Dizziness—Paclitaxel—ovarian cancer	8.02e-05	0.000519	CcSEcCtD
Sparfloxacin—Alopecia—Doxorubicin—ovarian cancer	7.98e-05	0.000516	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	7.91e-05	0.00692	CbGpPWpGaD
Sparfloxacin—Ill-defined disorder—Epirubicin—ovarian cancer	7.88e-05	0.00051	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—RAD51C—ovarian cancer	7.84e-05	0.00685	CbGpPWpGaD
Sparfloxacin—Agitation—Epirubicin—ovarian cancer	7.81e-05	0.000505	CcSEcCtD
Sparfloxacin—Flatulence—Doxorubicin—ovarian cancer	7.74e-05	0.000501	CcSEcCtD
Sparfloxacin—Tension—Doxorubicin—ovarian cancer	7.71e-05	0.000499	CcSEcCtD
Sparfloxacin—Vomiting—Paclitaxel—ovarian cancer	7.71e-05	0.000499	CcSEcCtD
Sparfloxacin—Dysgeusia—Doxorubicin—ovarian cancer	7.7e-05	0.000498	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—PPP1CC—ovarian cancer	7.67e-05	0.0067	CbGpPWpGaD
Sparfloxacin—Malaise—Epirubicin—ovarian cancer	7.66e-05	0.000495	CcSEcCtD
Sparfloxacin—Rash—Paclitaxel—ovarian cancer	7.64e-05	0.000495	CcSEcCtD
Sparfloxacin—Dermatitis—Paclitaxel—ovarian cancer	7.64e-05	0.000494	CcSEcCtD
Sparfloxacin—Nervousness—Doxorubicin—ovarian cancer	7.63e-05	0.000494	CcSEcCtD
Sparfloxacin—Vertigo—Epirubicin—ovarian cancer	7.63e-05	0.000494	CcSEcCtD
Sparfloxacin—Back pain—Doxorubicin—ovarian cancer	7.6e-05	0.000492	CcSEcCtD
Sparfloxacin—Headache—Paclitaxel—ovarian cancer	7.6e-05	0.000491	CcSEcCtD
Sparfloxacin—Hypersensitivity—Docetaxel—ovarian cancer	7.57e-05	0.00049	CcSEcCtD
Sparfloxacin—Palpitations—Epirubicin—ovarian cancer	7.51e-05	0.000486	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	7.41e-05	0.00648	CbGpPWpGaD
Sparfloxacin—Cough—Epirubicin—ovarian cancer	7.41e-05	0.000479	CcSEcCtD
Sparfloxacin—ABCC2—NRF2 pathway—SLC5A5—ovarian cancer	7.39e-05	0.00646	CbGpPWpGaD
Sparfloxacin—Asthenia—Docetaxel—ovarian cancer	7.37e-05	0.000477	CcSEcCtD
Sparfloxacin—Convulsion—Epirubicin—ovarian cancer	7.36e-05	0.000476	CcSEcCtD
Sparfloxacin—Hypertension—Epirubicin—ovarian cancer	7.33e-05	0.000474	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	7.32e-05	0.0064	CbGpPWpGaD
Sparfloxacin—Ill-defined disorder—Doxorubicin—ovarian cancer	7.29e-05	0.000472	CcSEcCtD
Sparfloxacin—Pruritus—Docetaxel—ovarian cancer	7.27e-05	0.00047	CcSEcCtD
Sparfloxacin—Chest pain—Epirubicin—ovarian cancer	7.23e-05	0.000468	CcSEcCtD
Sparfloxacin—Arthralgia—Epirubicin—ovarian cancer	7.23e-05	0.000468	CcSEcCtD
Sparfloxacin—Myalgia—Epirubicin—ovarian cancer	7.23e-05	0.000468	CcSEcCtD
Sparfloxacin—Agitation—Doxorubicin—ovarian cancer	7.22e-05	0.000467	CcSEcCtD
Sparfloxacin—Anxiety—Epirubicin—ovarian cancer	7.21e-05	0.000466	CcSEcCtD
Sparfloxacin—Nausea—Paclitaxel—ovarian cancer	7.2e-05	0.000466	CcSEcCtD
Sparfloxacin—Discomfort—Epirubicin—ovarian cancer	7.14e-05	0.000462	CcSEcCtD
Sparfloxacin—ABCC2—NRF2 pathway—SLC2A1—ovarian cancer	7.14e-05	0.00624	CbGpPWpGaD
Sparfloxacin—Malaise—Doxorubicin—ovarian cancer	7.09e-05	0.000458	CcSEcCtD
Sparfloxacin—Dry mouth—Epirubicin—ovarian cancer	7.07e-05	0.000457	CcSEcCtD
Sparfloxacin—Vertigo—Doxorubicin—ovarian cancer	7.06e-05	0.000457	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—RBL2—ovarian cancer	7.04e-05	0.00615	CbGpPWpGaD
Sparfloxacin—Diarrhoea—Docetaxel—ovarian cancer	7.03e-05	0.000455	CcSEcCtD
Sparfloxacin—Confusional state—Epirubicin—ovarian cancer	6.99e-05	0.000452	CcSEcCtD
Sparfloxacin—Palpitations—Doxorubicin—ovarian cancer	6.94e-05	0.000449	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Epirubicin—ovarian cancer	6.93e-05	0.000448	CcSEcCtD
Sparfloxacin—Cough—Doxorubicin—ovarian cancer	6.86e-05	0.000444	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—PPP1CC—ovarian cancer	6.85e-05	0.00599	CbGpPWpGaD
Sparfloxacin—Convulsion—Doxorubicin—ovarian cancer	6.81e-05	0.00044	CcSEcCtD
Sparfloxacin—Dizziness—Docetaxel—ovarian cancer	6.8e-05	0.00044	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Epirubicin—ovarian cancer	6.79e-05	0.000439	CcSEcCtD
Sparfloxacin—Hypertension—Doxorubicin—ovarian cancer	6.79e-05	0.000439	CcSEcCtD
Sparfloxacin—Tachycardia—Epirubicin—ovarian cancer	6.77e-05	0.000438	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	6.71e-05	0.00586	CbGpPWpGaD
Sparfloxacin—Hyperhidrosis—Epirubicin—ovarian cancer	6.7e-05	0.000433	CcSEcCtD
Sparfloxacin—Myalgia—Doxorubicin—ovarian cancer	6.69e-05	0.000433	CcSEcCtD
Sparfloxacin—Chest pain—Doxorubicin—ovarian cancer	6.69e-05	0.000433	CcSEcCtD
Sparfloxacin—Arthralgia—Doxorubicin—ovarian cancer	6.69e-05	0.000433	CcSEcCtD
Sparfloxacin—Anxiety—Doxorubicin—ovarian cancer	6.67e-05	0.000431	CcSEcCtD
Sparfloxacin—Discomfort—Doxorubicin—ovarian cancer	6.61e-05	0.000428	CcSEcCtD
Sparfloxacin—Anorexia—Epirubicin—ovarian cancer	6.61e-05	0.000427	CcSEcCtD
Sparfloxacin—Dry mouth—Doxorubicin—ovarian cancer	6.54e-05	0.000423	CcSEcCtD
Sparfloxacin—Vomiting—Docetaxel—ovarian cancer	6.53e-05	0.000423	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	6.49e-05	0.00568	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	6.49e-05	0.00568	CbGpPWpGaD
Sparfloxacin—Rash—Docetaxel—ovarian cancer	6.48e-05	0.000419	CcSEcCtD
Sparfloxacin—Dermatitis—Docetaxel—ovarian cancer	6.47e-05	0.000419	CcSEcCtD
Sparfloxacin—Confusional state—Doxorubicin—ovarian cancer	6.47e-05	0.000418	CcSEcCtD
Sparfloxacin—Headache—Docetaxel—ovarian cancer	6.44e-05	0.000416	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Doxorubicin—ovarian cancer	6.41e-05	0.000415	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—AQP3—ovarian cancer	6.41e-05	0.0056	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	6.38e-05	0.00557	CbGpPWpGaD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	6.37e-05	0.00557	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—ovarian cancer	6.34e-05	0.00554	CbGpPWpGaD
Sparfloxacin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	6.32e-05	0.000409	CcSEcCtD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—ovarian cancer	6.31e-05	0.00552	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—RBL2—ovarian cancer	6.29e-05	0.0055	CbGpPWpGaD
Sparfloxacin—Thrombocytopenia—Doxorubicin—ovarian cancer	6.28e-05	0.000406	CcSEcCtD
Sparfloxacin—Insomnia—Epirubicin—ovarian cancer	6.27e-05	0.000406	CcSEcCtD
Sparfloxacin—Tachycardia—Doxorubicin—ovarian cancer	6.26e-05	0.000405	CcSEcCtD
Sparfloxacin—Paraesthesia—Epirubicin—ovarian cancer	6.22e-05	0.000403	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Doxorubicin—ovarian cancer	6.2e-05	0.000401	CcSEcCtD
Sparfloxacin—Dyspnoea—Epirubicin—ovarian cancer	6.18e-05	0.0004	CcSEcCtD
Sparfloxacin—Somnolence—Epirubicin—ovarian cancer	6.16e-05	0.000399	CcSEcCtD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	6.16e-05	0.00538	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ATP7B—ovarian cancer	6.14e-05	0.00537	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—TYMS—ovarian cancer	6.12e-05	0.00535	CbGpPWpGaD
Sparfloxacin—Anorexia—Doxorubicin—ovarian cancer	6.11e-05	0.000395	CcSEcCtD
Sparfloxacin—Nausea—Docetaxel—ovarian cancer	6.1e-05	0.000395	CcSEcCtD
Sparfloxacin—Dyspepsia—Epirubicin—ovarian cancer	6.1e-05	0.000395	CcSEcCtD
Sparfloxacin—Decreased appetite—Epirubicin—ovarian cancer	6.03e-05	0.00039	CcSEcCtD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—ovarian cancer	6.02e-05	0.00527	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	5.97e-05	0.00521	CbGpPWpGaD
Sparfloxacin—Constipation—Epirubicin—ovarian cancer	5.93e-05	0.000383	CcSEcCtD
Sparfloxacin—Pain—Epirubicin—ovarian cancer	5.93e-05	0.000383	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	5.84e-05	0.000378	CcSEcCtD
Sparfloxacin—Insomnia—Doxorubicin—ovarian cancer	5.8e-05	0.000375	CcSEcCtD
Sparfloxacin—Paraesthesia—Doxorubicin—ovarian cancer	5.76e-05	0.000373	CcSEcCtD
Sparfloxacin—Dyspnoea—Doxorubicin—ovarian cancer	5.72e-05	0.00037	CcSEcCtD
Sparfloxacin—Feeling abnormal—Epirubicin—ovarian cancer	5.71e-05	0.00037	CcSEcCtD
Sparfloxacin—Somnolence—Doxorubicin—ovarian cancer	5.7e-05	0.000369	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Epirubicin—ovarian cancer	5.67e-05	0.000367	CcSEcCtD
Sparfloxacin—Dyspepsia—Doxorubicin—ovarian cancer	5.65e-05	0.000365	CcSEcCtD
Sparfloxacin—Decreased appetite—Doxorubicin—ovarian cancer	5.58e-05	0.000361	CcSEcCtD
Sparfloxacin—Urticaria—Epirubicin—ovarian cancer	5.51e-05	0.000356	CcSEcCtD
Sparfloxacin—Constipation—Doxorubicin—ovarian cancer	5.48e-05	0.000355	CcSEcCtD
Sparfloxacin—Pain—Doxorubicin—ovarian cancer	5.48e-05	0.000355	CcSEcCtD
Sparfloxacin—Abdominal pain—Epirubicin—ovarian cancer	5.48e-05	0.000354	CcSEcCtD
Sparfloxacin—Body temperature increased—Epirubicin—ovarian cancer	5.48e-05	0.000354	CcSEcCtD
Sparfloxacin—Feeling abnormal—Doxorubicin—ovarian cancer	5.29e-05	0.000342	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Doxorubicin—ovarian cancer	5.24e-05	0.000339	CcSEcCtD
Sparfloxacin—Hypersensitivity—Epirubicin—ovarian cancer	5.11e-05	0.00033	CcSEcCtD
Sparfloxacin—Urticaria—Doxorubicin—ovarian cancer	5.1e-05	0.00033	CcSEcCtD
Sparfloxacin—Abdominal pain—Doxorubicin—ovarian cancer	5.07e-05	0.000328	CcSEcCtD
Sparfloxacin—Body temperature increased—Doxorubicin—ovarian cancer	5.07e-05	0.000328	CcSEcCtD
Sparfloxacin—Asthenia—Epirubicin—ovarian cancer	4.97e-05	0.000322	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	4.95e-05	0.00433	CbGpPWpGaD
Sparfloxacin—Pruritus—Epirubicin—ovarian cancer	4.9e-05	0.000317	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—TUBB3—ovarian cancer	4.85e-05	0.00424	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—ovarian cancer	4.83e-05	0.00422	CbGpPWpGaD
Sparfloxacin—Diarrhoea—Epirubicin—ovarian cancer	4.74e-05	0.000307	CcSEcCtD
Sparfloxacin—Hypersensitivity—Doxorubicin—ovarian cancer	4.73e-05	0.000306	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—AQP3—ovarian cancer	4.68e-05	0.00409	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—SKP2—ovarian cancer	4.68e-05	0.00409	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	4.68e-05	0.00409	CbGpPWpGaD
Sparfloxacin—Asthenia—Doxorubicin—ovarian cancer	4.6e-05	0.000298	CcSEcCtD
Sparfloxacin—Dizziness—Epirubicin—ovarian cancer	4.58e-05	0.000297	CcSEcCtD
Sparfloxacin—Pruritus—Doxorubicin—ovarian cancer	4.54e-05	0.000294	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	4.49e-05	0.00392	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—ovarian cancer	4.44e-05	0.00388	CbGpPWpGaD
Sparfloxacin—Vomiting—Epirubicin—ovarian cancer	4.41e-05	0.000285	CcSEcCtD
Sparfloxacin—Diarrhoea—Doxorubicin—ovarian cancer	4.39e-05	0.000284	CcSEcCtD
Sparfloxacin—Rash—Epirubicin—ovarian cancer	4.37e-05	0.000283	CcSEcCtD
Sparfloxacin—Dermatitis—Epirubicin—ovarian cancer	4.37e-05	0.000282	CcSEcCtD
Sparfloxacin—Headache—Epirubicin—ovarian cancer	4.34e-05	0.000281	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—TERT—ovarian cancer	4.28e-05	0.00374	CbGpPWpGaD
Sparfloxacin—Dizziness—Doxorubicin—ovarian cancer	4.24e-05	0.000274	CcSEcCtD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—ovarian cancer	4.24e-05	0.0037	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MLH1—ovarian cancer	4.23e-05	0.0037	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—SKP2—ovarian cancer	4.19e-05	0.00366	CbGpPWpGaD
Sparfloxacin—Nausea—Epirubicin—ovarian cancer	4.12e-05	0.000266	CcSEcCtD
Sparfloxacin—Vomiting—Doxorubicin—ovarian cancer	4.08e-05	0.000264	CcSEcCtD
Sparfloxacin—Rash—Doxorubicin—ovarian cancer	4.04e-05	0.000262	CcSEcCtD
Sparfloxacin—Dermatitis—Doxorubicin—ovarian cancer	4.04e-05	0.000261	CcSEcCtD
Sparfloxacin—Headache—Doxorubicin—ovarian cancer	4.02e-05	0.00026	CcSEcCtD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	3.97e-05	0.00347	CbGpPWpGaD
Sparfloxacin—Nausea—Doxorubicin—ovarian cancer	3.81e-05	0.000246	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	3.63e-05	0.00318	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—ovarian cancer	3.59e-05	0.00314	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	3.55e-05	0.0031	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CHEK2—ovarian cancer	3.42e-05	0.00299	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—ovarian cancer	3.4e-05	0.00297	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	3.39e-05	0.00296	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	3.37e-05	0.00294	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	3.3e-05	0.00288	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ovarian cancer	3.29e-05	0.00288	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.24e-05	0.00283	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	3.21e-05	0.00281	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—BRCA1—ovarian cancer	3.21e-05	0.00281	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CCND2—ovarian cancer	3.21e-05	0.00281	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	3.18e-05	0.00278	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CCNE1—ovarian cancer	3.14e-05	0.00275	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.13e-05	0.00273	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	3.1e-05	0.00271	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—ovarian cancer	3.09e-05	0.0027	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—PPP2R1A—ovarian cancer	3.03e-05	0.00265	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—PTEN—ovarian cancer	2.98e-05	0.0026	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—BRCA2—ovarian cancer	2.9e-05	0.00254	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	2.85e-05	0.00249	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CCNE1—ovarian cancer	2.81e-05	0.00246	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	2.8e-05	0.00245	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—ovarian cancer	2.78e-05	0.00243	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—TYMS—ovarian cancer	2.76e-05	0.00241	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	2.65e-05	0.00231	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	2.61e-05	0.00228	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	2.58e-05	0.00225	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	2.52e-05	0.0022	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	2.52e-05	0.0022	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	2.52e-05	0.0022	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—BIRC5—ovarian cancer	2.48e-05	0.00217	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.47e-05	0.00216	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	2.44e-05	0.00213	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—TERT—ovarian cancer	2.4e-05	0.0021	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	2.38e-05	0.00208	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.37e-05	0.00207	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	2.3e-05	0.00201	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.29e-05	0.002	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	2.21e-05	0.00193	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	2.2e-05	0.00192	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CASP3—ovarian cancer	2.2e-05	0.00192	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IL2—ovarian cancer	2.2e-05	0.00192	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	2.19e-05	0.00191	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	2.16e-05	0.00189	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	2.14e-05	0.00187	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	2.12e-05	0.00185	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	2.11e-05	0.00185	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	2.1e-05	0.00184	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—TP53—ovarian cancer	2.03e-05	0.00178	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	1.87e-05	0.00163	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—IL6—ovarian cancer	1.86e-05	0.00162	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.81e-05	0.00158	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.79e-05	0.00156	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NME2—ovarian cancer	1.72e-05	0.0015	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	1.67e-05	0.00146	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	1.63e-05	0.00143	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	1.63e-05	0.00142	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—ovarian cancer	1.55e-05	0.00136	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	1.54e-05	0.00135	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDKN1B—ovarian cancer	1.46e-05	0.00127	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CCND1—ovarian cancer	1.39e-05	0.00121	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	1.38e-05	0.0012	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—ovarian cancer	1.28e-05	0.00112	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MYC—ovarian cancer	1.25e-05	0.00109	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—ovarian cancer	1.22e-05	0.00107	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.2e-05	0.00105	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MAPK3—ovarian cancer	1.15e-05	0.001	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MYC—ovarian cancer	1.11e-05	0.000975	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.11e-05	0.000973	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYTB—ovarian cancer	1.11e-05	0.00097	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.11e-05	0.000969	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MAPK1—ovarian cancer	1.09e-05	0.000953	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.09e-05	0.00095	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.08e-05	0.00094	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.06e-05	0.000924	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.05e-05	0.000915	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.02e-05	0.000892	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—BRIP1—ovarian cancer	9.7e-06	0.000848	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PPP1CC—ovarian cancer	9.7e-06	0.000848	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	9.22e-06	0.000806	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—TP53—ovarian cancer	9.16e-06	0.0008	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	8.72e-06	0.000762	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	8.48e-06	0.000741	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	8.3e-06	0.000725	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	8.3e-06	0.000725	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	7.84e-06	0.000685	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	7.2e-06	0.000629	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	6.97e-06	0.000609	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—YAP1—ovarian cancer	6.5e-06	0.000568	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	5.88e-06	0.000514	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—FASN—ovarian cancer	5.3e-06	0.000463	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC5A5—ovarian cancer	5.22e-06	0.000456	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC2A1—ovarian cancer	5.04e-06	0.00044	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP1B1—ovarian cancer	4.83e-06	0.000422	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PPP2R1A—ovarian cancer	4.28e-06	0.000374	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—TYMS—ovarian cancer	3.91e-06	0.000341	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CAV1—ovarian cancer	3.15e-06	0.000275	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CG—ovarian cancer	2.87e-06	0.000251	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CD—ovarian cancer	2.52e-06	0.00022	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.2e-06	0.000192	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PTEN—ovarian cancer	1.9e-06	0.000166	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.34e-06	0.000117	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AKT1—ovarian cancer	1.09e-06	9.56e-05	CbGpPWpGaD
